This effect is further supported by VEGFA, which also shows significant variations between T0 and T3, as well as between the control and T3 (p < 0.05), reinforcing the critical role mediated by sEVs in vascularization within RP patients (Figure 6O). The gene discussed is VEGFA; the disease is retinitis pigmentosa 1.